Author

Shuji Osugi

Institution: Kobe Central Hospital

Observed institutions: Kanazawa University, Kyoto Prefectural University of Medicine, Kobe Central Hospital, Japan Community Healthcare Organization

ORCID: 0000-0002-8571-9932

Observed ORCID: 0000-0002-8571-9932

OpenAlex ID: A5060163532

A novel potent inhibitor of inducible nitric oxide synthase, ONO-1714, reduces hyperoxic lung injury in mice

2006 · Tatsuya Yuba, Kazuhiro Nagata, et al. · Respiratory Medicine · 8

Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective study

2022 · Sayaka Uda, Tadaaki Yamada, et al. · Translational Lung Cancer Research · 6

Prognostic factors in patients with interstitial lung disease treated with nintedanib: a multicenter retrospective study in Japan

2025 · Shiho Goda, Tadaaki Yamada, et al. · Scientific Reports · 3

[Spinal cord metastases in lung cancer: a clinical review of four cases].

2005 · Hiroomi Kuwahara, Tadaaki Yamada, et al. · PubMed · 3

Non-small Cell Lung Cancer with Second Pseudoprogression After an Increase in the Nivolumab Dose: a Case Report

2019 · Ryota Nakamura, Fumitaka Mito, et al. · Haigan · 1

[A case of sarcoidosis with diffuse pulmonary arteriovenous malformations].

2005 · Hiroomi Kuwahara, Tadaaki Yamada, et al. · PubMed · 1

Efficacy and safety of nintedanib for older adults with idiopathic pulmonary fibrosis or progressive fibrosing interstitial lung disease: A multicenter retrospective study in Japan

2026 · Shiho Goda, Tadaaki Yamada, et al. · Respiratory Investigation

Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease

2026 · Shiho Goda, Tadaaki Yamada, et al. · BMC Pulmonary Medicine

[Six cases of thymic carcinoma: a clinical review].

2004 · Yoshizumi Takemura, Tatsuya Yuba, et al. · PubMed

Works count: 9

Citation count: 22

H-index: 3

I10-index: